The European Commission has approved the COVID-19 vaccine made by Novavax.
It comes after the jab was recommended for approval by the European Medicines Agency (EMA) earlier today.
The EMA recommended the jab for people aged 18 and over.
Novavax and the European Commission announced an advance purchase agreement for up to 200 million doses of the vaccine, upon it being approved, in August.
Earlier today, the company said it would be ready to start delivering doses to the EU in the first quarter of 2022.
